Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T and B Lymphocyte Transcriptional States Differentiate between Sensitized and Unsensitized Individuals in Alpha-Gal Syndrome. | Int J Mol Sci | 2021 | 33804792 | PubTator, text mining | PubMed |
| Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer. | Int J Mol Sci | 2021 | 33804263 | PubTator, text mining | PubMed |
| Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. | Int J Mol Sci | 2021 | 33802091 | PubTator, text mining | PubMed |
| Novel Virulence Role of Pneumococcal NanA in Host Inflammation and Cell Death Through the Activation of Inflammasome and the Caspase Pathway. | Front Cell Infect Microbiol | 2021 | 33777832 | PubTator, text mining | PubMed |
| Targeting KRAS: The Elephant in the Room of Epithelial Cancers. | Front Oncol | 2021 | 33777798 | PubTator, text mining | PubMed |
| Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer. | PLoS One | 2021 | 33760860 | PubTator, text mining | PubMed |
| [Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps]. | HNO | 2021 | 33738558 | PubTator, text mining | PubMed |
| GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line. | Stem Cell Res Ther | 2021 | 33736688 | PubTator, text mining | PubMed |
| Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development. | Front Immunol | 2021 | 33732245 | PubTator, text mining | PubMed |
| Application of text mining to develop AOP-based mucus hypersecretion genesets and confirmation with in vitro and clinical samples. | Sci Rep | 2021 | 33731770 | PubTator, text mining | PubMed |
| Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. | J Allergy Clin Immunol Pract | 2021 | 33685604 | PubTator, text mining | PubMed |
| Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role? | Int J Mol Sci | 2021 | 33671049 | PubTator, text mining | PubMed |
| Modulating Th2 Cell Immunity for the Treatment of Asthma. | Front Immunol | 2021 | 33643321 | PubTator, text mining | PubMed |
| Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease. | Int J Rheum Dis | 2021 | 33638296 | PubTator, text mining | PubMed |
| Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. | Biomed Res Int | 2021 | 33628816 | PubTator, text mining | PubMed |
| Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review. | Dermatol Ther (Heidelb) | 2021 | 33599887 | PubTator, text mining | PubMed |
| Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer. | Sci Rep | 2021 | 33597614 | PubTator, text mining | PubMed |
| CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens. | Mol Cell Proteomics | 2021 | 33592498 | PubTator, text mining | PubMed |
| IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma. | PLoS One | 2021 | 33591997 | PubTator, text mining | PubMed |
| The magnitude of airway remodeling is not altered by distinct allergic inflammatory responses in BALB/c versus C57BL/6 mice but matrix composition differs. | Immunol Cell Biol | 2021 | 33587776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=37